CBL Prop CBL Q4 2024 Earnings Beat Revenue NA EPS 122 Why Galaxy GLXG Just Surged 100 Key Levels Ahead 20260520 USCB USCB Q1 2026 Beat Revenue NA EPS Exceeds by Significant Regeneron Pharmaceuticals REGN Q1 2026 Results Top Views on Strong Revenue LiqTech International LIQT Reports Mixed Q1 2026 Revenue Beats but EPS Misses Quanta Services PWR Reports Strong Q1 2026 Revenue NA EPS Beats